Exclusive Summary

• Highly safe and effective gastroprokinetic agent perfectly replacing cisapride by eliminating life-threatening cardiovascular side effects.
• A massive global patient base for Functional Dyspepsia and GERD drives rigid, high-frequency medication demand in targeted emerging markets.
• Patent-expired generic ready for distribution partnerships, offering an absolute pricing advantage to ensure lucrative local profit margins.
• Backed by China's robust API-to-formulation integrated supply chain and complete bioequivalence data to support fast-track local MOH registrations.